Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)

Daniela Intini, Luca Baldini, Sonia Fabris, Luigia Lombardi, Gabriella Ciceri, Anna Teresa Maiolo, Antonino Neri

Research output: Contribution to journalArticlepeer-review


The t(4;14)(p16.3;q32) in multiple myeloma (MM) leads to an apparent deregulation of the FGFR3 and WHSC1/MMSET genes. FGFR3 mutations, known to be associated with genetic skeletal disorders, have also been identified in a few cases of MM (mainly cell lines) with t(4;14). We investigated FGFR3 mutations in a series of 53 MM cases; 11 cases with t(4;14) and FGFR3 overexpression were analysed using reverse transcription polymerase chain reaction, while the remaining cases were studied at DNA level. The Arg248Cys mutation, which is associated with some lethal forms of skeletal disorders, was found in one case with t(4;14). Our results indicate that FGFR3 mutations occur in only a small fraction of MM cases with t(4;14).

Original languageEnglish
Pages (from-to)362-364
Number of pages3
JournalBritish Journal of Haematology
Issue number2
Publication statusPublished - 2001


  • FGFR3 mutations
  • Multiple myeloma
  • t(4;14)

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)'. Together they form a unique fingerprint.

Cite this